Literature DB >> 17999848

Gallstone disease and type-2 diabetes mellitus-the link.

Olokoba A B1, Bojuwoye B J, Olokoba L B, Braimoh K T, Inikori A K.   

Abstract

OBJECTIVE: To determine the factors predisposing patients with type-2 diabetes mellitus to gallstone disease.
DESIGN: Case-control study. PLACE AND DURATION OF STUDY: The medical outpatient clinic of the University of Ilorin teaching hospital, Ilorin, Nigeria, from July, 2003 to June, 2004. PATIENTS AND METHODS: One hundred type 2 diabetic patients and 100 age and gender-matched controls underwent real time ultrasonography to study factors predisposing patients with type 2 diabetes mellitus to gallstone disease. The age, gender, body mass index (BMI), duration of diabetes mellitus and serum lipids were determined in the individuals enrolled for the study.
RESULTS: Fifteen percent of the diabetic patients had ultrasound evidence of gallstone disease as compared to 7% in non-diabetic controls. There was a steady increase in the incidence of gallstone disease in diabetic patients with age with a peak incidence in the seventh decade i.e. 60-69 years, and a decline in the eighth decade i.e. 70 - 79 years. The average age of the diabetic patients with gallstone disease - 59.1+ 9.5 years was significantly higher than in those without gallstone disease - 51.8 + 10.5 years (p = 0.014). The mean duration of disease in the diabetic patients with gallstone disease was 5.0 + 4.9 years compared with 4.5 + 3.8 years in the diabetic patients without gallstone disease (p=0.772). The mean serum cholesterol and triglyceride levels - 4.3 + 1.3 mmol/L and 1.5 + 0.8 mmol/L respectively in the diabetic patients with gallstone disease was higher than in those without gallstone disease - 3.4 + 0.5 mmol/L (p=0.0941) and 1.4 + 0.7 mmol/L (p=0.712) respectively. The mean body mass index for the diabetic patients with gallstone disease was 26.2 + 5.5 kg /m2 compared with 25.7 + 6.7 kg/m2 in those without gallstone disease (p=0.755) .
CONCLUSION: Increasing age is a risk factor for gallstone disease in diabetic patients. Hyperlipidaemia, female gender, heavier weight and a longer duration of diabetes mellitus appear to be associated risk factors.

Entities:  

Year:  2007        PMID: 17999848     DOI: 10.2007/JCPSP.594597

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  5 in total

1.  Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified?

Authors:  Antonio Ramos-De la Medina; José M Remes-Troche; Federico B Roesch-Dietlen; Alfonso G Pérez-Morales; Silvia Martinez; Silvia Cid-Juarez
Journal:  J Gastrointest Surg       Date:  2008-09-30       Impact factor: 3.452

Review 2.  Epidemiology, management, and economic evaluation of screening of gallstone disease among type 2 diabetics: A systematic review.

Authors:  Lujie Chen; Yu-Ting Peng; Fu-Li Chen; Tao-Hsin Tung
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

3.  Prevalence of gallstone disease in patients with type 2 diabetes and the risk factors in North Indian population: a case control study.

Authors:  Jaswinder Singh Sodhi; Showkat Ali Zargar; Shafkatullah Khateeb; Abid Showkat; Gul Javid; Bashir Ahmad Laway; Shaheena Parveen; Bashir Ahmad Khan; Ghulam Nabi Yattoo; Altaf Shah; Ghulam Mohd Gulzar; Mushtaq Ahmed Khan
Journal:  Indian J Gastroenterol       Date:  2014-10-07

4.  Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.

Authors:  Anna Ludovica Fracanzani; Luca Valenti; Maurizio Russello; Luca Miele; Cristina Bertelli; Alessandro Bellia; Chiara Masetti; Consuelo Cefalo; Antonio Grieco; Giulio Marchesini; Silvia Fargion
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

5.  Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study.

Authors:  Rebecca A Noel; Daniel K Braun; Ruth E Patterson; Gary L Bloomgren
Journal:  Diabetes Care       Date:  2009-02-10       Impact factor: 17.152

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.